Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

15.02
Delayed Data
As of 4:00pm ET
 -0.30 / -1.96%
Today’s Change
10.55
Today|||52-Week Range
26.47
-5.59%
Year-to-Date
No recent news for Sagent Pharmaceuticals Inc.

Today’s Trading

Previous close15.32
Today’s open14.53
Day’s range14.53 - 15.11
Volume1,104,920
Average volume (3 months)389,205
Market cap$503.1M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-154.92%
Earnings growth (this year)+147.36%
Earnings growth (next 5 years)+88.75%
Revenue growth (last year)+10.14%
P/E ratioNM
Price/Sales1.62
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...-0.24-2.19%
ARRYArray Biopharma Inc-0.13-3.63%
LOXOLoxo Oncology Inc-0.53-2.20%
VNDAVanda Pharmaceutical...-0.19-1.67%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$318.3M
Annual profit (last year)-$21.9M
Net profit margin-6.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Allan Oberman
Executive Vice President-
Global Operations
J. Frank Harmon
Corporate headquarters
Schaumburg, Illinois

Forecasts

Partner Offers

Search for Jobs